Skip to main content

Table 2 Patient characteristics

From: Early assessment of response to induction therapy in acute myeloid leukemia using 18F-FLT PET/CT

Patient no.

Age

Sex

ECOG PS

Risk status

BM blasts (%)

BM cellularity (%)

WBC (× 109/L)

Hb (g/dL)

Platelet (× 109/L)

LDH (U/L)

1

60

M

1

Poor

52

52

40.86

11.6

57

450

2

72

M

1

Indeterminate

30

30–40

3.23

4.7

27

378

3

40

F

1

Indeterminate

8

90

2.65

9.8

191

136

4

48

F

1

Indeterminate

33

80–90

2.1

7.2

112

124

5

66

M

0

Indeterminate

45

50

13.3

9.6

50

216

6

36

F

1

Favorable

21

80

17.34

7

10

571

7

73

M

2

Poor

39

100

19.02

4.6

10

606

8

19

M

1

Indeterminate

68

100

21.43

4.8

35

825

9

60

M

3

Favorable

25

80

30.72

3

11

706

10

55

M

2

Favorable

26

80

14.18

8.4

56

1144

  1. ECOG PS Eastern Cooperative Oncology Group performance status, Hb hemoglobin